Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Zaprinast

Home DrugsZaprinast

Zaprinast

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Indications

用于单纯性支气管哮喘、喘息型慢性支气管炎。对过敏性鼻炎、过敏性皮炎也有一定疗效。

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Use of phosphodiesterase inhibitors in the treatment of prostatic diseases
Applicant: FORSSMANN WOLF-GEORGPriority: 2000
US
5 publications
Composition for preventing or treating degenerative brain diseases including compound downregulating expression of BACE1 proteins
Applicant: UNIV SUNGKYUNKWAN RES & BUSPriority: 2013
US
2 publications
Use of phosphodiesterase 5 (PDE5) inhibitors in the treatment of schizophrenia
Applicant: OAK LABS CORPPriority: 2005
US
USE OF PDE5 INHIBITORS FOR TREATING CIRCADIAN RHYTHM DISORDERS
Applicant: CONSEJO NAC INVEST CIENT TECPriority: 2008
US